What is the recommended dose of Deriphyllin (theophylline) per kilogram for a patient with asthma or chronic obstructive pulmonary disease (COPD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Deriphyllin (Theophylline) Dosing Per Kilogram

For intravenous loading: 4.6 mg/kg theophylline (5.7 mg/kg as aminophylline) over 30 minutes produces an average serum concentration of 10 mcg/mL; for maintenance infusion: 0.4 mg/kg/hr in non-smoking adults or 0.8 mg/kg/hr in children age 1-9 years. 1

Loading Dose Administration

The standard loading dose is 4.6 mg/kg of theophylline (5.7 mg/kg as aminophylline) calculated on ideal body weight, administered intravenously over 30 minutes. 1 This produces a maximum post-distribution serum concentration averaging 10 mcg/mL with a range of 6-16 mcg/mL. 1

Critical Considerations Before Loading:

  • Do not give a loading dose if the patient has received any theophylline in the previous 24 hours without first obtaining a serum level. 1
  • If prior theophylline use is confirmed, calculate the loading dose as: D = (Desired C - Measured C) × 0.5 L/kg, where desired concentration should be conservative at 10 mcg/mL. 1
  • Each mg/kg administered increases serum concentration by approximately 2 mcg/mL on average. 1

Maintenance Infusion Rates

After the loading dose, initiate continuous infusion based on patient population:

Non-Smoking Adults:

  • 0.4 mg/kg/hr theophylline (0.5 mg/kg/hr as aminophylline) achieves steady-state of 10 mcg/mL (range 7-26 mcg/mL). 1

Children Age 1-9 Years:

  • 0.8 mg/kg/hr theophylline (1.0 mg/kg/hr as aminophylline) achieves similar steady-state concentrations. 1

Elderly Patients (>60 years):

  • Reduce dose by 30% as clearance decreases by an average of 30% compared to young adults. 1

Patients with Hepatic Insufficiency or CHF:

  • Reduce dose by 50% or more as clearance is decreased by 50% or more in these populations. 1

Smokers:

  • May require higher doses as tobacco smoking increases theophylline clearance through metabolic pathway induction. 1

Therapeutic Monitoring Algorithm

Obtain serum theophylline concentration 30 minutes after loading dose completion to assess need for additional loading and guide continuing therapy. 1

Obtain second serum concentration one expected half-life after starting constant infusion:

  • Approximately 4 hours in children age 1-9 years 1
  • Approximately 8 hours in non-smoking adults 1

Target therapeutic range: 5-15 mcg/mL for optimal bronchodilation with minimal side effects. 2 The European Respiratory Society recommends adjusting doses to achieve peak serum levels of 5-15 μg/L. 2

Clinical Context and Positioning

Theophyllines should only be tried in severe COPD patients who remain symptomatic despite combination β2-agonist and anticholinergic bronchodilators, and must be monitored closely for side effects. 3 The British Thoracic Society guidelines emphasize that oral bronchodilators are not usually required in moderate disease. 3

Important Caveats:

  • Wide interpatient variability exists in theophylline clearance, causing fourfold differences in dose requirements among similar patients. 1
  • Nonlinear elimination may begin at concentrations <10 mcg/mL in some patients, requiring small incremental dose adjustments. 1
  • Neonates require special attention: approximately 50% is excreted unchanged in urine (versus 10% in older children/adults), necessitating careful dose reduction and frequent monitoring. 1
  • No renal dose adjustment needed in adults and children >3 months of age, as only 10% is excreted unchanged. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.